Nomura Asset Management CO LTD Moon Lake Immunotherapeutics Transaction History

Nomura Asset Management CO LTD

  • $31.8 Billion
  • Q3 2024
Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024
BUY
$40.15 - $55.4 $0 - $0
0 New
0 $0
Q2 2024

Aug 14, 2024
BUY
$38.43 - $48.6 $0 - $0
0 New
0 $0
Q1 2024

May 13, 2024
BUY
$43.78 - $63.86 $0 - $0
0 New
0 $0
Q4 2023

Feb 09, 2024
BUY
$36.35 - $63.02 $0 - $0
0 New
0 $0
Q3 2023

Nov 03, 2023
BUY
$48.35 - $61.26 $0 - $0
0 New
0 $0
Q2 2023

Aug 14, 2023
BUY
$19.01 - $51.79 $0 - $0
0 New
0 $0

Others Institutions Holding MLTX

# of Institutions
124
Shares Held
58.2M
Call Options Held
52.2K
Put Options Held
38K
View Full List

About MoonLake Immunotherapeutics

MLTX Quotes by TradingView
  • Ticker MLTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,925,600
  • Market Cap $1.8B
  • Description
  • MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...
More about MLTX
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email